• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Incidence of non-melanoma skin cancer continues to increase in the USA

byShirin BajajandAdam Whittington
May 6, 2015
in Chronic Disease, Dermatology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The total number of non-melanoma skin cancers (NMSC) in the US population was estimated to have increased to 5,434,193 in 2012 from 4,013,890 in 2006.

Evidence Rating Level: 2 (Good)           

Study Rundown: Non-melanoma skin cancer (NMSC), which includes both basal and squamous cell carcinomas, is the most common malignancy in the United States. It is associated with tremendous financial burden on our healthcare system, and can cause significant morbidity for patients if treatment options are not pursued when the disease is in early stages. The authors of this study aimed to establish up-to-date and accurate estimates of the incidence of NMSC in the US Medicare fee-for-service population. They found that between 2006 and 2012 the incidence of NMSC increased by over a million cases, and the total number of fee-for-service Medicare skin cancer procedures increased by 13%. The large sample size strengthens this group’s findings; however using the Medicare fee-for-service population to approximate the rate of NMSCs per affected individual in the general population may have limited the accuracy.

Click to read the study in JAMA Dermatology

Relevant Reading: Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma

In-Depth [cross-sectional study]: Incidence estimates were made using two Medicare databases (Total Claims Data set and Medicare Limited Data Set Standard Analytic File 5% Sample Physician Supplier Data) as well as national survey data (National Ambulatory Medical Care Survey) from 2006 to 2012. The total number of procedures for NMSC in the Medicare fee-for-service population increased from 2,048,517 in 2006 to 2,321,058 in 2012. The age-adjusted rate of NMSC procedures increased from 6,075 per 100,000 beneficiaries in 2006 to 7,320 in 2012. The number of persons with at least one procedure for treatment of a NMSC increased by 14% from 2006 to 2012, although the average number of procedures per Medicare beneficiary stayed stable over this time-period. The number of skin cancers treated per patient was calculated to be 1.64. The ratio of BCC to SCC treated in the Medicare fee-for-service population was 1.0. The estimated incidence for NMSC in the US population in 2012 was 5,434,193, and the total number of persons in the US treated for NMSC the same year was estimated to be 3,315,554.

Image: PD

RELATED REPORTS

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

#VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma

#VisualAbstract: Adjuvant pembrolizumab improves distant metastasis-free survival in stage IIB-C melanoma

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: skin cancer
Previous Post

Zidovudine reduces maternal-infant HIV transmission [Classics Series]

Next Post

No difference between three methods of catheter ablation for persistent atrial fibrillation [STAR AF II]

RelatedReports

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma
StudyGraphics

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

March 15, 2023
#VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma
StudyGraphics

#VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma

March 9, 2023
#VisualAbstract: Adjuvant pembrolizumab improves distant  metastasis-free survival in stage IIB-C melanoma
StudyGraphics

#VisualAbstract: Adjuvant pembrolizumab improves distant metastasis-free survival in stage IIB-C melanoma

February 13, 2023
#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer
StudyGraphics

#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

October 20, 2022
Next Post
Radiofrequency catheter ablation effective as first-line therapy for atrial fibrillation [RAAFT-2 trial]

No difference between three methods of catheter ablation for persistent atrial fibrillation [STAR AF II]

Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors

Exercise associated with improved quality of life during chemotherapy

Cervical conization may double risk of preterm birth

Study finds variation in treatment of extremely pre-term infants among hospitals

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Expectant management of patent ductus arteriosus noninferior to early ibuprofen use
  • Exhaled volatile organic compounds predict bronchopulmonary dysplasia in preterm infants
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options